[{"AccountsPayableCurrent_0_Q3_USD":59564000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-3309000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-6154000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-3309000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-6163000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-9000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-9000.0,"OtherLiabilitiesCurrent_0_Q3_USD":3637000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-2739000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-4394000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-8328000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":0.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":2167000.0,"PaymentsToAcquireProductiveAssets_3_Q3_USD":41122000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":28088000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-6154000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-3309000.0,"OtherAssetsNoncurrent_0_Q3_USD":38340000.0,"Liabilities_0_Q3_USD":2104605000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":2565941000.0,"LiabilitiesCurrent_0_Q3_USD":1753415000.0,"LongTermDebtPercentageBearingFixedInterestRate_0_Q3_pure":0.0375,"MarketableSecuritiesCurrent_0_Q3_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":522424000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":116518000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":665354000.0,"NetIncomeLoss_1_Q3_USD":-322431000.0,"NetIncomeLoss_3_Q3_USD":-897467000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"OperatingIncomeLoss_1_Q3_USD":-307144000.0,"OperatingIncomeLoss_3_Q3_USD":-861605000.0,"OperatingLeaseExpense_1_Q3_USD":4400000.0,"OperatingLeaseExpense_3_Q3_USD":17100000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":119047000.0,"InvestmentIncomeNet_3_Q3_USD":1061000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":564859000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":159807000.0,"StockholdersEquity_0_Q3_USD":461336000.0,"StockIssued1_3_Q3_USD":0.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":564859000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.01,"TemporaryEquitySharesAuthorized_0_Q3_shares":2000000.0,"ShortTermLeaseCost_3_Q3_USD":325500000.0,"TemporaryEquitySharesIssued_0_Q3_shares":0.0,"TreasuryStockShares_0_Q3_shares":557749.0,"TreasuryStockValue_0_Q3_USD":79132000.0,"UnamortizedDebtIssuanceExpense_0_Q3_USD":1898000.0,"UnbilledReceivablesCurrent_0_Q3_USD":34678000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":74745000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":73972000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":0.0,"ShortTermLeaseCost_1_Q3_USD":111300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":673000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":156.86,"PropertyPlantAndEquipmentNet_0_Q3_USD":214751000.0,"ReceivablesNetCurrent_0_Q3_USD":75283000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":408195000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":1571551000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":8175000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":1653000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-2771666000.0,"Revenues_1_Q3_USD":178844000.0,"Revenues_3_Q3_USD":924090000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q3_USD":11400000.0,"SecurityDeposit_0_Q3_USD":1500000.0,"ShareBasedCompensation_3_Q3_USD":151457000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":212000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":381000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":203.51,"ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_3_Q3_USD":0.0,"InvestmentIncomeNet_1_Q3_USD":330000.0,"InterestPaidNet_3_Q3_USD":17768000.0,"InterestExpenseDebtExcludingAmortization_3_Q3_USD":9141000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CommonStockSharesAuthorized_0_Q3_shares":600000000.0,"CommonStockSharesIssued_0_Q3_shares":75973523.0,"CommonStockSharesOutstanding_0_Q3_shares":75415774.0,"CommonStockValue_0_Q3_USD":760000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-325740000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-903630000.0,"CostsAndExpenses_1_Q3_USD":485988000.0,"CostsAndExpenses_3_Q3_USD":1785695000.0,"CurrentForeignTaxExpenseBenefit_1_Q3_USD":6000000.0,"CurrentForeignTaxExpenseBenefit_3_Q3_USD":12600000.0,"DebtInstrumentFaceAmount_0_Q3_USD":325000000.0,"DeferredRevenueCurrent_0_Q3_USD":1262360000.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":323102000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":1298088000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":1946826000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1936998000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":323867000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q3_USD":900000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":861000.0,"AdditionalPaidInCapital_0_Q3_USD":3310513000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":151457000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":45274000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_3_Q3_USD":7292000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":45274000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":151457000.0,"AmortizationOfFinancingCosts_1_Q3_USD":356000.0,"AmortizationOfFinancingCosts_3_Q3_USD":1068000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":300000.0,"Assets_0_Q3_USD":2565941000.0,"AssetsCurrent_0_Q3_USD":2174181000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":7884000.0,"EarningsPerShareBasic_1_Q3_USD":-4.31,"EarningsPerShareBasic_3_Q3_USD":-12.13,"EarningsPerShareDiluted_1_Q3_USD":-4.31,"EarningsPerShareDiluted_3_Q3_USD":-12.13,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":-3390000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-316390000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-884861000.0,"IncomeTaxesPaidNet_3_Q3_USD":6041000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":6041000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":12606000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":180708000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":992590000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-209221000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":5027000.0,"InterestExpense_1_Q3_USD":5182000.0,"InterestExpense_3_Q3_USD":15989000.0,"InterestExpenseDebt_1_Q3_USD":3403000.0,"InterestExpenseDebt_3_Q3_USD":10209000.0,"InterestExpenseDebtExcludingAmortization_1_Q3_USD":3047000.0,"Goodwill_0_Q3_USD":131989000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":74745000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":214144000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":5027000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-6208000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":209000000.0,"FinanceLeaseInterestExpense_1_Q3_USD":1600000.0,"FinanceLeaseInterestExpense_3_Q3_USD":5600000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":103987000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":0.0,"FinanceLeasePrincipalPayments_3_Q3_USD":63876000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":7305000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":425000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":106000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q3_USD":425000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":425000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":425000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":425000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":12332000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":77793000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":73972000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]